Sakamori Y - Search Results

1

Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.

Masago K, Fujita S, Kim YH, Hatachi Y, Fukuhara A, Irisa K, Nagai H, Sakamori Y, Togashi Y, Mio T, Mishima M. Masago K, et al. Among authors: sakamori y. Cancer Chemother Pharmacol. 2011 Feb;67(2):325-30. doi: 10.1007/s00280-010-1321-1. Epub 2010 Apr 17. Cancer Chemother Pharmacol. 2011. PMID: 20401614 Clinical Trial.

2

Identification and characterization of the genes for N-acetylglucosamine kinase and N-acetylglucosamine-phosphate deacetylase in the pathogenic fungus Candida albicans.

Yamada-Okabe T, Sakamori Y, Mio T, Yamada-Okabe H. Yamada-Okabe T, et al. Among authors: sakamori y. Eur J Biochem. 2001 Apr;268(8):2498-505. doi: 10.1046/j.1432-1327.2001.02135.x. Eur J Biochem. 2001. PMID: 11298769 Free article.

3

Pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer and chronic renal failure who are undergoing hemodialysis.

Togashi Y, Masago K, Fukudo M, Terada T, Ikemi Y, Kim YH, Fujita S, Irisa K, Sakamori Y, Mio T, Inui K, Mishima M. Togashi Y, et al. Among authors: sakamori y. J Thorac Oncol. 2010 May;5(5):601-5. doi: 10.1097/JTO.0b013e3181d32287. J Thorac Oncol. 2010. PMID: 20234322 Free article.

4

Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.

Masago K, Fujita S, Mio T, Togashi Y, Kim YH, Hatachi Y, Fukuhara A, Irisa K, Sakamori Y, Mishima M. Masago K, et al. Among authors: sakamori y. Med Oncol. 2011 Mar;28(1):351-6. doi: 10.1007/s12032-010-9454-y. Epub 2010 Mar 19. Med Oncol. 2011. PMID: 20300980

5

Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancer.

Togashi Y, Masago K, Fukudo M, Terada T, Fujita S, Irisa K, Sakamori Y, Kim YH, Mio T, Inui K, Mishima M. Togashi Y, et al. Among authors: sakamori y. J Thorac Oncol. 2010 Jul;5(7):950-5. doi: 10.1097/JTO.0b013e3181e2138b. J Thorac Oncol. 2010. PMID: 20479691 Free article.

6

Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation.

Masago K, Togashi Y, Fukudo M, Terada T, Irisa K, Sakamori Y, Fujita S, Kim YH, Mio T, Inui KI, Mishima M. Masago K, et al. Among authors: sakamori y. Case Rep Oncol. 2010 Apr 22;3(2):98-105. doi: 10.1159/000310830. Case Rep Oncol. 2010. PMID: 20740181 Free PMC article.

7

Octreotide, a somatostatin analogue, in the treatment of chylothorax associated with idiopathic fibrosing mediastinitis.

Togashi Y, Kim YH, Miyahara R, Irisa K, Sakamori Y, Masago K, Mio T, Date H, Mishima M. Togashi Y, et al. Among authors: sakamori y. Tohoku J Exp Med. 2010 Sep;222(1):51-3. doi: 10.1620/tjem.222.51. Tohoku J Exp Med. 2010. PMID: 20814178 Free article.

8

Outcome of Surgical Treatment for Metastatic Vertebra Bone Tumor in Advanced Lung Cancer.

Fukuhara A, Masago K, Neo M, Fujibayashi S, Fujita S, Hatachi Y, Irisa K, Sakamori Y, Togashi Y, Kim YH, Mio T, Mishima M. Fukuhara A, et al. Among authors: sakamori y. Case Rep Oncol. 2010 Mar 24;3(1):63-71. doi: 10.1159/000299385. Case Rep Oncol. 2010. PMID: 20844571 Free PMC article.

9

Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.

Togashi Y, Masago K, Kubo T, Sakamori Y, Kim YH, Hatachi Y, Fukuhara A, Mio T, Togashi K, Mishima M. Togashi Y, et al. Among authors: sakamori y. Cancer. 2011 Feb 15;117(4):819-25. doi: 10.1002/cncr.25618. Epub 2010 Sep 30. Cancer. 2011. PMID: 20886633 Free article.

10

Pulmonary embolism due to internal jugular vein thrombosis in a patient with non-small cell lung cancer receiving bevacizumab.

Togashi Y, Kim YH, Masago K, Tamai K, Sakamori Y, Mio T, Mishima M. Togashi Y, et al. Among authors: sakamori y. Int J Clin Oncol. 2011 Aug;16(4):444-6. doi: 10.1007/s10147-010-0148-4. Epub 2010 Nov 30. Int J Clin Oncol. 2011. PMID: 21116671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters